Flavio Frohlich, Ph.D., University of North Carolina, Chapel Hill, will conduct a trial of a non-invasive brain stimulation method developed in his lab for the treatment of patients with major depressive disorder. This method uniquely provides adaptive, individualized stimulation. Called “feedback transcranial alternating current stimulation,” it manipulates brain activity through a weak electric current, not … Read more

Dr. Flavio Frohlich, along with colleague Dr. Jenny Bizley, has received a $750,000 Human Frontier Science research grant.

Beth Knight, a graduate student in Mohanish Deshmukh’s lab, has found a novel gene that could be targeted for medulloblastoma. Beth’s research identified the ASC gene to be essential for medulloblastoma in mouse models. This finding was unexpected because ASC is typically associated with the detection of pathogens. However, Beth found that ASC is highly … Read more

The Prize award ceremony and lecture was held on Feb 20th at 3PM in G202 MBRB with a reception to follow.

Autism Speaks, the world’s leading autism science and advocacy organization, selected Ben Philpot and Mark Zylka’s research on the underlying causes of autism as one of the top 10 advances in autism research of 2013. To read more, click here.

Roth lab’s publication in Nature identifies a way for more precisely targeted therapies for a host of brain diseases including chronic pain, Parkinson’s disease, and depression. A link to more information on their discoveries can be found here. To read the full publication, click here.

UNC neuroscientist Juan Song discovers how baby neurons stay alive, a key finding for understanding neurodegenerative diseases, such as Alzheimer’s.

Once unknown in the field of autism, UNC’s Mark Zylka is now uncovering potential causes for the brain disorder!